English

RBC LIFE SCIENCES, INC.

EDGAR

Quarterly report (10-Q) · filed 2015-11-16

85 filing records in this dataset, filed from 1997-04-14 to 2015-11-16. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.41 million USD

2015 Q3 · USD

Exact inputs and evidence

Revenue: 5405885 USD Source

Operating margin

10.4%

2015 Q3 · %

Exact inputs and evidence

Operating Income: 562007 USD Source
Revenue: 5405885 USD Source

Operating cash flow

-2.75 million USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -3590213 USD Source
Operating Cash Flow: -836764 USD Source

Free cash flow

-2.9 million USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -3590213 USD Source
Operating Cash Flow: -836764 USD Source
Capital Expenditure: 142000 USD Source

Cash and cash equivalents: 2.09 million USD 2015-09-30 Source
Exact value

2091450 USD
Long-term debt including current maturities: 0 USD 2015-09-30 Source
Exact value

0 USD
Shares outstanding: 2.21 million shares 2015-09-30 Source
Exact value

2212350 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2212350 shares · 2014-09-30· Source
2212350 shares · 2015-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

17 million USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Revenue: 7157 USD · 2014-10-01 – 2014-12-31 Source
Revenue: 5359810 USD · 2015-01-01 – 2015-03-31 Source
Revenue: 6192404 USD · 2015-04-01 – 2015-06-30 Source
Revenue: 5405885 USD · 2015-07-01 – 2015-09-30 Source

Net income

-465 thousand USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Net income: 0 USD · 2014-10-01 – 2014-12-31 Source
Net income: -549990 USD · 2015-01-01 – 2015-03-31 Source
Net income: -245628 USD · 2015-04-01 – 2015-06-30 Source
Net income: 330749 USD · 2015-07-01 – 2015-09-30 Source

Capital expenditure

383 thousand USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Capital expenditure: 1074436 USD · 2014-01-01 – 2014-12-31 Source
Capital expenditure: 870588 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 37649 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 0 USD · 2015-04-01 – 2015-06-30 Source
Capital expenditure: 142000 USD · 2015-07-01 – 2015-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-11-16.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2014-12-31
Operating income: 6 of 11 periods available· newest 2014-12-31
Net income: 6 of 11 periods available· newest 2014-12-31
Operating cash flow: 6 of 11 periods available· newest 2014-12-31
Capital expenditure: 6 of 11 periods available· newest 2014-12-31
Total assets: 6 of 11 periods available· newest 2014-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2014-12-31
Current liabilities: 6 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2014-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2014-12-31
Shares outstanding: 5 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+11%

Prior period

USD 25.47 million

2013-01-01 – 2013-12-31
Current period

USD 28.27 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

28270448 − 25470934 = 2799514 USD

25470934 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
28270448 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Year-over-year change in Revenue: 2799514 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 28270448 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#167267 Filing: 000083005215000005 Input fundies:Revenue: 25470934 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#164495 Filing: 000083005215000005
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 102,806

Prior period

−USD 500,005

2013-01-01 – 2013-12-31
Current period

−USD 602,811

2014-01-01 – 2014-12-31

Exact inputs and evidence

-602811 − -500005 = -102806 USD

-500005 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-602811 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Year-over-year change in Net income: -102806 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -602811 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#147431 Filing: 000083005215000005 Input fundies:NetIncome: -500005 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#146476 Filing: 000083005215000005
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-306.5%

Prior period

USD 294,232

2013-01-01 – 2013-12-31
Current period

−USD 607,732

2014-01-01 – 2014-12-31

Exact inputs and evidence

-607732 − 294232 = -901964 USD

294232 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-607732 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Year-over-year change in Operating cash flow: -901964 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -607732 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#145683 Filing: 000083005215000005 Input fundies:OperatingCashFlow: 294232 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#145475 Filing: 000083005215000005
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+302.3%

Prior period

USD 267,055

2013-01-01 – 2013-12-31
Current period

USD 1.07 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

1074436 − 267055 = 807381 USD

267055 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
1074436 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Year-over-year change in Capital expenditure: 807381 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1074436 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#155270 Filing: 000083005215000005 Input fundies:CapitalExpenditure: 267055 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#154515 Filing: 000083005215000005
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 28.27 million 100% of revenue
Cost of revenue USD 12.63 million 45% of revenue
Operating expenses USD 16.26 million 58% of revenue
Operating income −USD 625,266 −2.2% of revenue
Tax, interest and other Derived −USD 22,455 −0.1% of revenue
Net income −USD 602,811 −2.1% of revenue

Cash

Operating cash flow −USD 607,732 −2.1% of revenue
Capital expenditure USD 1.07 million 3.8% of revenue
Free cash flow Derived −USD 1.68 million −6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 101% of revenue.
2010 96%
2011 Operating loss: operating costs were 100% of revenue.
2012 Operating loss: operating costs were 102% of revenue.
2013 Operating loss: operating costs were 102% of revenue.
2014 Operating loss: operating costs were 102% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	24924581	25084198 Derived	-159617	175236 Derived	-334853	-976432 Derived	Source 2009-01-01 – 2009-12-31: 24924581 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -159617 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -334853 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 158320 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 1134752 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	28157010	27113239 Derived	1043771	486025 Derived	557746	381462 Derived	Source 2010-01-01 – 2010-12-31: 28157010 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 1043771 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 557746 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 544731 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 163269 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	28447967	28518852 Derived	-70885	609 Derived	-71494	-225117 Derived	Source 2011-01-01 – 2011-12-31: 28447967 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -70885 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -71494 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 125297 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 350414 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	25160172	25623765 Derived	-463593	-102157 Derived	-361436	-360033 Derived	Source 2012-01-01 – 2012-12-31: 25160172 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -463593 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -361436 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 445352 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 805385 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	25470934	26095558 Derived	-624624	-124619 Derived	-500005	27177 Derived	Source 2013-01-01 – 2013-12-31: 25470934 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -624624 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -500005 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 294232 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 267055 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	28270448	28895714 Derived	-625266	-22455 Derived	-602811	-1682168 Derived	Source 2014-01-01 – 2014-12-31: 28270448 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -625266 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -602811 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -607732 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 1074436 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 28.3M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	24924581	Revenue: 24924581 Open source
20102010-12-31	Revenue	28157010	Revenue: 28157010 Open source
20112011-12-31	Revenue	28447967	Revenue: 28447967 Open source
20122012-12-31	Revenue	25160172	Revenue: 25160172 Open source
20132013-12-31	Revenue	25470934	Revenue: 25470934 Open source
20142014-12-31	Revenue	28270448	Revenue: 28270448 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

11% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 24924581 Open source
20102010-12-31	Year over year	13%	Revenue: 28157010 Open source Revenue: 24924581 Open source
20112011-12-31	Year over year	1%	Revenue: 28447967 Open source Revenue: 28157010 Open source
20122012-12-31	Year over year	-11.6%	Revenue: 25160172 Open source Revenue: 28447967 Open source
20132013-12-31	Year over year	1.2%	Revenue: 25470934 Open source Revenue: 25160172 Open source
20142014-12-31	Year over year	11%	Revenue: 28270448 Open source Revenue: 25470934 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2.2% 2014

Net margin -2.1% 2014

Free cash flow margin -6% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-0.6%	Operating Income: -159617 Open source Revenue: 24924581 Open source
20102010-12-31	Operating margin	3.7%	Operating Income: 1043771 Open source Revenue: 28157010 Open source
20112011-12-31	Operating margin	-0.2%	Operating Income: -70885 Open source Revenue: 28447967 Open source
20122012-12-31	Operating margin	-1.8%	Operating Income: -463593 Open source Revenue: 25160172 Open source
20132013-12-31	Operating margin	-2.5%	Operating Income: -624624 Open source Revenue: 25470934 Open source
20142014-12-31	Operating margin	-2.2%	Operating Income: -625266 Open source Revenue: 28270448 Open source
20092009-12-31	Net margin	-1.3%	Net Income: -334853 Open source Revenue: 24924581 Open source
20102010-12-31	Net margin	2%	Net Income: 557746 Open source Revenue: 28157010 Open source
20112011-12-31	Net margin	-0.3%	Net Income: -71494 Open source Revenue: 28447967 Open source
20122012-12-31	Net margin	-1.4%	Net Income: -361436 Open source Revenue: 25160172 Open source
20132013-12-31	Net margin	-2%	Net Income: -500005 Open source Revenue: 25470934 Open source
20142014-12-31	Net margin	-2.1%	Net Income: -602811 Open source Revenue: 28270448 Open source
20092009-12-31	Free cash flow margin	-3.9%	Revenue: 24924581 Open source Operating Cash Flow: 158320 Open source Capital Expenditure: 1134752 Open source
20102010-12-31	Free cash flow margin	1.4%	Revenue: 28157010 Open source Operating Cash Flow: 544731 Open source Capital Expenditure: 163269 Open source
20112011-12-31	Free cash flow margin	-0.8%	Revenue: 28447967 Open source Operating Cash Flow: 125297 Open source Capital Expenditure: 350414 Open source
20122012-12-31	Free cash flow margin	-1.4%	Revenue: 25160172 Open source Operating Cash Flow: 445352 Open source Capital Expenditure: 805385 Open source
20132013-12-31	Free cash flow margin	0.1%	Revenue: 25470934 Open source Operating Cash Flow: 294232 Open source Capital Expenditure: 267055 Open source
20142014-12-31	Free cash flow margin	-6%	Revenue: 28270448 Open source Operating Cash Flow: -607732 Open source Capital Expenditure: 1074436 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -607.7K 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	158320	Operating Cash Flow: 158320 Open source
20102010-12-31	Operating cash flow	544731	Operating Cash Flow: 544731 Open source
20112011-12-31	Operating cash flow	125297	Operating Cash Flow: 125297 Open source
20122012-12-31	Operating cash flow	445352	Operating Cash Flow: 445352 Open source
20132013-12-31	Operating cash flow	294232	Operating Cash Flow: 294232 Open source
20142014-12-31	Operating cash flow	-607732	Operating Cash Flow: -607732 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.7M 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	-976432	Operating Cash Flow: 158320 Open source Capital Expenditure: 1134752 Open source
20102010-12-31	Free cash flow	381462	Operating Cash Flow: 544731 Open source Capital Expenditure: 163269 Open source
20112011-12-31	Free cash flow	-225117	Operating Cash Flow: 125297 Open source Capital Expenditure: 350414 Open source
20122012-12-31	Free cash flow	-360033	Operating Cash Flow: 445352 Open source Capital Expenditure: 805385 Open source
20132013-12-31	Free cash flow	27177	Operating Cash Flow: 294232 Open source Capital Expenditure: 267055 Open source
20142014-12-31	Free cash flow	-1682168	Operating Cash Flow: -607732 Open source Capital Expenditure: 1074436 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	Total Assets: 18612624 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 18344000 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 18825746 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 18014421 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 17533510 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 15995944 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.45× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Current assets / current liabilities	1.71×	Current Assets: 11230052 Open source Current Liabilities: 6553958 Open source
20102010-12-31	Current assets / current liabilities	1.96×	Current Assets: 11258503 Open source Current Liabilities: 5745469 Open source
20112011-12-31	Current assets / current liabilities	1.87×	Current Assets: 11977227 Open source Current Liabilities: 6408919 Open source
20122012-12-31	Current assets / current liabilities	1.85×	Current Assets: 11153808 Open source Current Liabilities: 6033509 Open source
20132013-12-31	Current assets / current liabilities	1.66×	Current Assets: 11017668 Open source Current Liabilities: 6655185 Open source
20142014-12-31	Current assets / current liabilities	1.45×	Current Assets: 8847220 Open source Current Liabilities: 6107070 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 334,853 Exact value Exact value: -334853 USD 2009-01-01 – 2009-12-31: -334853 USD Inspect Net Income Open source Share or cite Citation for Net Income · RBC LIFE SCIENCES, INC. · 2009-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Net Income: -334853 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -334853 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005212000009/rbcl-20101231.xml#454902 Filing: 000083005212000009 The citation records this snapshot. The page link may show a newer release later.	USD 158,320 Exact value Exact value: 158320 USD 2009-01-01 – 2009-12-31: 158320 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RBC LIFE SCIENCES, INC. · 2009-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Operating Cash Flow: 158320 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 158320 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005212000009/rbcl-20101231.xml#453978 Filing: 000083005212000009 The citation records this snapshot. The page link may show a newer release later.	USD 1.13 million Exact value Exact value: 1134752 USD 2009-01-01 – 2009-12-31: 1134752 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RBC LIFE SCIENCES, INC. · 2009-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Capital Expenditure: 1134752 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1134752 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005212000009/rbcl-20101231.xml#459669 Filing: 000083005212000009 The citation records this snapshot. The page link may show a newer release later.	−USD 976,432 Calculation and evidence 158320 − 1134752 USD Exact free cash flow: -976432 USD 2009-01-01 – 2009-12-31: 158320 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 1134752 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RBC LIFE SCIENCES, INC. · 2009-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Free cash flow: -976432 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 158320 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005212000009/rbcl-20101231.xml#453978 Filing: 000083005212000009 Input fundies:CapitalExpenditure: 1134752 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005212000009/rbcl-20101231.xml#459669 Filing: 000083005212000009 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 557,746 Exact value Exact value: 557746 USD 2010-01-01 – 2010-12-31: 557746 USD Inspect Net Income Open source Share or cite Citation for Net Income · RBC LIFE SCIENCES, INC. · 2010-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Net Income: 557746 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 557746 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#592983 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.	USD 544,731 Exact value Exact value: 544731 USD 2010-01-01 – 2010-12-31: 544731 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RBC LIFE SCIENCES, INC. · 2010-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Operating Cash Flow: 544731 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 544731 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#592625 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.	USD 163,269 Exact value Exact value: 163269 USD 2010-01-01 – 2010-12-31: 163269 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RBC LIFE SCIENCES, INC. · 2010-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Capital Expenditure: 163269 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 163269 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#624810 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.	USD 381,462 Calculation and evidence 544731 − 163269 USD Exact free cash flow: 381462 USD 2010-01-01 – 2010-12-31: 544731 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 163269 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RBC LIFE SCIENCES, INC. · 2010-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Free cash flow: 381462 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 544731 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#592625 Filing: 000083005213000013 Input fundies:CapitalExpenditure: 163269 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#624810 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 71,494 Exact value Exact value: -71494 USD 2011-01-01 – 2011-12-31: -71494 USD Inspect Net Income Open source Share or cite Citation for Net Income · RBC LIFE SCIENCES, INC. · 2011-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Net Income: -71494 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -71494 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#592833 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.	USD 125,297 Exact value Exact value: 125297 USD 2011-01-01 – 2011-12-31: 125297 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RBC LIFE SCIENCES, INC. · 2011-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Operating Cash Flow: 125297 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 125297 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#592417 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.	USD 350,414 Exact value Exact value: 350414 USD 2011-01-01 – 2011-12-31: 350414 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RBC LIFE SCIENCES, INC. · 2011-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Capital Expenditure: 350414 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 350414 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#624394 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.	−USD 225,117 Calculation and evidence 125297 − 350414 USD Exact free cash flow: -225117 USD 2011-01-01 – 2011-12-31: 125297 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 350414 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RBC LIFE SCIENCES, INC. · 2011-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Free cash flow: -225117 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 125297 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#592417 Filing: 000083005213000013 Input fundies:CapitalExpenditure: 350414 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005213000013/rbcl-20121231.xml#624394 Filing: 000083005213000013 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 361,436 Exact value Exact value: -361436 USD 2012-01-01 – 2012-12-31: -361436 USD Inspect Net Income Open source Share or cite Citation for Net Income · RBC LIFE SCIENCES, INC. · 2012-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Net Income: -361436 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -361436 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005214000008/rbcl-20131231.xml#544973 Filing: 000083005214000008 The citation records this snapshot. The page link may show a newer release later.	USD 445,352 Exact value Exact value: 445352 USD 2012-01-01 – 2012-12-31: 445352 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RBC LIFE SCIENCES, INC. · 2012-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Operating Cash Flow: 445352 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 445352 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005214000008/rbcl-20131231.xml#544764 Filing: 000083005214000008 The citation records this snapshot. The page link may show a newer release later.	USD 805,385 Exact value Exact value: 805385 USD 2012-01-01 – 2012-12-31: 805385 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RBC LIFE SCIENCES, INC. · 2012-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Capital Expenditure: 805385 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 805385 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005214000008/rbcl-20131231.xml#578756 Filing: 000083005214000008 The citation records this snapshot. The page link may show a newer release later.	−USD 360,033 Calculation and evidence 445352 − 805385 USD Exact free cash flow: -360033 USD 2012-01-01 – 2012-12-31: 445352 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 805385 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RBC LIFE SCIENCES, INC. · 2012-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Free cash flow: -360033 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 445352 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005214000008/rbcl-20131231.xml#544764 Filing: 000083005214000008 Input fundies:CapitalExpenditure: 805385 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005214000008/rbcl-20131231.xml#578756 Filing: 000083005214000008 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 500,005 Exact value Exact value: -500005 USD 2013-01-01 – 2013-12-31: -500005 USD Inspect Net Income Open source Share or cite Citation for Net Income · RBC LIFE SCIENCES, INC. · 2013-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Net Income: -500005 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -500005 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#146476 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.	USD 294,232 Exact value Exact value: 294232 USD 2013-01-01 – 2013-12-31: 294232 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RBC LIFE SCIENCES, INC. · 2013-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Operating Cash Flow: 294232 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 294232 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#145475 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.	USD 267,055 Exact value Exact value: 267055 USD 2013-01-01 – 2013-12-31: 267055 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RBC LIFE SCIENCES, INC. · 2013-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Capital Expenditure: 267055 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 267055 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#154515 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.	USD 27,177 Calculation and evidence 294232 − 267055 USD Exact free cash flow: 27177 USD 2013-01-01 – 2013-12-31: 294232 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 267055 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RBC LIFE SCIENCES, INC. · 2013-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Free cash flow: 27177 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 294232 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#145475 Filing: 000083005215000005 Input fundies:CapitalExpenditure: 267055 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#154515 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 602,811 Exact value Exact value: -602811 USD 2014-01-01 – 2014-12-31: -602811 USD Inspect Net Income Open source Share or cite Citation for Net Income · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Net Income: -602811 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -602811 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#147431 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.	−USD 607,732 Exact value Exact value: -607732 USD 2014-01-01 – 2014-12-31: -607732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Operating Cash Flow: -607732 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -607732 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#145683 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.	USD 1.07 million Exact value Exact value: 1074436 USD 2014-01-01 – 2014-12-31: 1074436 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Capital Expenditure: 1074436 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1074436 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#155270 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.	−USD 1.68 million Calculation and evidence -607732 − 1074436 USD Exact free cash flow: -1682168 USD 2014-01-01 – 2014-12-31: -607732 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1074436 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RBC LIFE SCIENCES, INC. · 2014-12-31 RBC LIFE SCIENCES, INC. (edgar:830052) Free cash flow: -1682168 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:40:57Z Snapshot: 56bdd37a67c7c0541a557f4eaea7d88528254c6554153d48b56bb8719210e4ae Dimensions: Consolidated View: https://fundies.io/companies/edgar/830052?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -607732 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#145683 Filing: 000083005215000005 Input fundies:CapitalExpenditure: 1074436 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/830052/000083005215000005/rbcl-20141231.xml#155270 Filing: 000083005215000005 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 2,350 latest values · 2,350 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000830052, 830052, edgar:830052

Also known as GLOBENET INTERNATIONAL I INC, MIGHTY POWER USA INC, RBC LIFE SCIENCES, INC., ROYAL BODYCARE INC/NV

RBC LIFE SCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation